Public list: Pharma Startups (4732) Rare Diseases (230)

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases.

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases.

Company (IPO / Went public)

Phone: 888-302-4876

Fax: 512-305-0009

6836 Bee Cave Road
Building 3, Suite 200
Austin, 78746
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Savara $61.2M Jan 7, 2017
Agentase $0.1M Apr 9, 2004
Transcept Pharmaceuticals $70.5M Oct 31, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Savara Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 17 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dry powder vancomycin compositions and associated methods Nov 19, 2013 Feb 21, 2017 Patent
Dry powder vancomycin compositions and associated methods Dec 10, 2015 Application